Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Raymond James Downgrades CVS Health to Outperform, Raises Price Target to $120

Raymond James analyst John Ransom downgrades CVS Health (NYSE:CVS) from Strong Buy to Outperform and raises the price target from $115 to $120.
byBenzinga Newsdesk
February 14, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Raymond James analyst John Ransom downgrades CVS Health (NYSE:CVS) from Strong Buy to Outperform and raises the price target from $115 to $120.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0